Published in Am J Hosp Pharm on March 01, 1982
Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf (2000) 2.37
Efficacy of diazepam and meperidine in ambulatory pediatric patients undergoing endoscopy: a randomized, double-blind trial. J Pediatr Gastroenterol Nutr (1993) 2.19
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. Ann Pharmacother (1992) 2.13
Once-daily administration of aminoglycosides. Ann Pharmacother (1994) 1.73
Teaching paediatric pharmacotherapy at colleges of pharmacy in the United States and Canada. J Clin Pharm Ther (1994) 1.48
Issues facing clinical pharmacy education for undergraduate students. DICP (1989) 1.40
Role of the ketogenic diet in children with intractable seizures. Ann Pharmacother (1998) 1.39
Standard room temperature needed for stability and compatibility studies. Am J Hosp Pharm (1993) 1.39
Treatment of listeriosis. Ann Pharmacother (2000) 1.32
Need for conducting research on medications unlabeled for use in pediatric patients. Ann Pharmacother (1994) 1.30
Clinical use of systemic antifungal agents. Clin Pharm (1988) 1.23
Clinical pharmacokinetics of antibacterial drugs in neonates. Clin Pharmacokinet (1990) 1.21
Chloramphenicol serum concentration falls during chloramphenicol succinate dosing. Clin Pharmacol Ther (1983) 1.16
Serum albumin beads: an injectable, biodegradable system for the sustained release of drugs. Science (1981) 1.12
Glycerol: a review of its pharmacology, pharmacokinetics, adverse reactions, and clinical use. Pharmacotherapy (1986) 1.12
In-vitro and in-vivo studies of the diclofenac sodium controlled-release matrix tablets. J Pharm Pharmacol (1995) 1.12
Pediatric drug formulations: challenges and potential solutions. Ann Pharmacother (1999) 1.09
Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. J Pharmacol Exp Ther (1982) 1.08
The influence of cosolvents on the in-vitro percutaneous penetration of diclofenac sodium from a gel system. J Pharm Pharmacol (1994) 1.07
Pharmacokinetics of amphotericin B in children. Antimicrob Agents Chemother (1989) 1.07
Dosage guidelines for the use of vancomycin based on its pharmacokinetics in infants. Eur J Clin Pharmacol (1988) 1.05
Complication of intranasal midazolam. Pediatrics (1993) 1.03
Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm (1987) 1.03
Tight binding affinities determined from thermodynamic linkage to protons by titration calorimetry. Methods Enzymol (1995) 1.02
Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization. Ther Drug Monit (1987) 1.02
Medication errors in a nurse-controlled parenteral admixture program. Am J Hosp Pharm (1972) 1.01
Pathogenesis and treatment of bronchiolitis. Clin Pharm (1993) 0.99
Nelfinavir mesylate: a protease inhibitor. Ann Pharmacother (1999) 0.96
A comparative review of conventional and lipid formulations of amphotericin B. J Clin Pharm Ther (1999) 0.95
Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy. Chemotherapy (1987) 0.95
Variation in morphine pharmacokinetics in children with cancer. Dev Pharmacol Ther (1985) 0.95
Acetaminophen accumulation in pediatric patients after repeated therapeutic doses. Eur J Clin Pharmacol (1984) 0.95
Medication errors reduced by unit-dose. Hospitals (1973) 0.95
Adverse effects of meperidine, promethazine, and chlorpromazine for sedation in pediatric patients. Clin Pediatr (Phila) (1985) 0.94
Determination of cefaclor by high-performance liquid chromatography. J Chromatogr (1982) 0.94
Antimicrobial dosages in guidelines for prevention of bacterial endocarditis. Clin Pharm (1991) 0.94
Effect of gestational age and birth weight on tobramycin kinetics in newborn infants. J Antimicrob Chemother (1984) 0.94
Pharmacokinetics of dexamethasone in premature neonates. Eur J Clin Pharmacol (1996) 0.93
Ganciclovir--a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections. J Clin Pharm Ther (1989) 0.93
Clinical use of trimethoprim/sulfamethoxazole during renal dysfunction. DICP (1989) 0.93
Circular dichroism and solution conformation of the tetracycline antibiotics. Tetrahedron Lett (1968) 0.92
Efficacy of amlodipine in pediatric patients with hypertension. Pediatr Nephrol (1999) 0.92
Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis. Ann Pharmacother (1995) 0.92
Pharmacokinetics of cefuroxime axetil suspension in infants and children. Antimicrob Agents Chemother (1991) 0.91
Effect of infusion methods on tobramycin serum concentrations in newborn infants. J Pediatr (1984) 0.91
Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias. Clin Pharmacol Ther (1978) 0.91
Interaction of various tetracyclines with metallic cations in aqueous solutions as measured by by circular dichroism. Antimicrob Agents Chemother (Bethesda) (1969) 0.91
Oral terbinafine: a new antifungal agent. Ann Pharmacother (1997) 0.90
Delivery of tobramycin by three infusion systems. Chemotherapy (1984) 0.89
Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis. Chest (1997) 0.89
Efficacy and safety of aerosolized tobramycin in cystic fibrosis. Pediatr Pulmonol (2001) 0.89
Pharmacokinetics of netilmicin in premature infants. Eur J Clin Pharmacol (1986) 0.88
Bacterial contamination of aerosol solutions used to treat cystic fibrosis. Am J Hosp Pharm (1982) 0.87
Entrapment of bioactive compounds within native albumin beads: II. Effects of rate and extent of crosslinking on microbead properties. J Parenter Sci Technol (1987) 0.87
Bioavailability and clearance of chloramphenicol after intravenous chloramphenicol succinate. Clin Pharmacol Ther (1981) 0.87
Research productivity and funding. DICP (1991) 0.87
Circular dichroism and solution conformation of the tetracycline antibiotics. Antimicrob Agents Chemother (Bethesda) (1968) 0.87
Sulbactam/ampicillin, a new beta-lactamase inhibitor/beta-lactam antibiotic combination. Drug Intell Clin Pharm (1988) 0.85
Treatment of irritable bowel syndrome. J Clin Pharm Ther (2010) 0.85
Pharmacokinetics of phenytoin in children with acute neurotrauma. Crit Care Med (1995) 0.85
Effect of ascorbic acid on urine pH in man. Am J Hosp Pharm (1977) 0.84
Clinical uses of fentanyl, sufentanil, and alfentanil. Clin Pharm (1991) 0.84
Interlot variability in gentamicin and tobramycin concentration and its possible significance. Ther Drug Monit (1986) 0.84
Efficacy of ototopical ciprofloxacin in pediatric patients with otorrhea. Otolaryngol Head Neck Surg (1997) 0.84
Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol. Res Commun Chem Pathol Pharmacol (1975) 0.83
Chronic suppurative otitis media. Ann Pharmacother (1994) 0.83
Pharmacologic management of patent ductus arteriosus. Clin Pharm (1989) 0.83
Treatment of pediatric hypertension. Pharmacotherapy (2000) 0.83
Moxalactam epimer kinetics in children. Clin Pharmacol Ther (1982) 0.82
Kinetics of concomitant degradation of tetracycline to epitetracycline, anhydrotetracycline, and epianhydrotetracycline in acid phosphate solution. J Pharm Sci (1977) 0.82
Interactions among chloramphenicol, phenytoin, and phenobarbital in a pediatric patient. J Pediatr (1981) 0.82
Kinetics of dehydration of epitetracycline in solution. J Pharm Sci (1974) 0.82
Periorbital cellulitis secondary to Conidiobolus incongruus. Pharmacotherapy (2001) 0.82
Cephalexin pharmacokinetics in patients with cystic fibrosis. Dev Pharmacol Ther (1984) 0.82
Gastrostomy tube placement in nonadherent HIV-infected children. Ann Pharmacother (2001) 0.82
Tobramycin pharmacokinetics in very low birth weight infants. Br J Clin Pharmacol (1986) 0.82
Use of the 295- to 300-nanometer circular dichroism through of ribonucleic acid to study helix winding: effect of acridine orange. Antimicrob Agents Chemother (1973) 0.82
Dopamine and dobutamine in pediatric therapy. Pharmacotherapy (1989) 0.82
Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement. Chemotherapy (1990) 0.81
Loss of nitroglycerin from aqueous solution into plastic intravenous delivery systems. J Pharm Sci (1979) 0.81
The safety and antiviral effect of protease inhibitors in children. Pharmacotherapy (2001) 0.81
Effect of intravenous flow rate and injection site on in vitro delivery of chloramphenicol succinate and in vivo kinetics. J Pediatr (1981) 0.81
Evaluation of antiproliferative agents using a cell-culture model. Invest Ophthalmol Vis Sci (1990) 0.81
Stability of antibiotics frozen and stored in disposable hypodermic syringes. Am J Hosp Pharm (1980) 0.81
Tobramycin kinetics in newborn infants. J Pediatr (1983) 0.81
Rimantadine: a clinical perspective. Ann Pharmacother (1995) 0.80
Variations in glycerol kinetics in Reye's syndrome. Clin Pharmacol Ther (1981) 0.80
Response to initial griseofulvin therapy in pediatric patients with tinea capitis. Ann Pharmacother (1997) 0.80
Dopamine pharmacokinetics in critically ill newborn infants. Eur J Clin Pharmacol (1991) 0.80
Juvenile amaurotic family idiocy with cherry-red spot and cataract. Indian J Ophthalmol (1973) 0.80
Comparative palatability of 22 liquid antacids. Aliment Pharmacol Ther (2000) 0.80
Comparative bioavailability and pharmacokinetics of chloramphenicol after intravenous chloramphenicol succinate in premature infants and older patients. Dev Pharmacol Ther (1983) 0.80
Palatability of 14 over-the-counter antacids. Am Pharm (1994) 0.80
Clinical use of fluoroquinolones in children. Ann Pharmacother (2000) 0.80
Duration of penicillin prophylaxis in sickle cell anemia: issues and controversies. Pharmacotherapy (2000) 0.79
Effect of histamine H2-receptor antagonists on vitamin B12 absorption. Ann Pharmacother (1992) 0.79
Efficacy of itraconazole in children with Trichophyton tonsurans tinea capitis. J Am Acad Dermatol (1998) 0.79
Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection. Am J Health Syst Pharm (2000) 0.79
Trovafloxacin: a new fluoroquinolone. Ann Pharmacother (1999) 0.79
Pharmacotherapy of lower limb diabetic ulcers. J Am Geriatr Soc (2000) 0.79